Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2002
Published online before print September 12, 2002, doi: 10.1161/01.RES.0000036749.73316.73
A more recent version of this article appeared on October 4, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/7/633    most recent
01.RES.0000036749.73316.73v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, H.
Right arrow Articles by Raizada, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, H.
Right arrow Articles by Raizada, M. K.

Submitted on April 25, 2002
Revised on August 29, 2002
Accepted on August 29, 2002

Hypertension-Linked Decrease in the Expression of Brain {gamma}-Adducin

Hong Yang ; Sharon C. Francis ; Kathleen Sellers ; Mia DeBarros ; Chengwen Sun ; Colin Sumners ; Carlos M. Ferrario ; Michael J. Katovich ; Andrës F. Muro ; and Mohan K. Raizada *

From the Department of Physiology and Functional Genomics (H.Y., S.C.F., K.S., M.D., C. Sun, C. Sumners, M.K.R.) College of Medicine and University of Florida McKnight Brain Institute, Gainesville, Fla; the Department of Pharmacodynamics (M.J.K.), College of Pharmacy, University of Florida, Gainesville, Fla; The Hypertension and Vascular Disease Center (C.M.F.), Wake Forest University School of Medicine, Winston-Salem, NC; and the International Center for Genetic Engineering and Biotechnology (A.F.M.), Trieste, Italy.

* To whom correspondence should be addressed. E-mail: mraizada{at}phys.med.ufl.edu.

Gene profiling data coupled with adducin polymorphism studies led us to hypothesize that decreased expression of this cytosolic protein in the brain could be a key event in the central control of hypertension. Thus, our objectives in the present study were to (1) determine which adducin subunit gene demonstrates altered expression in the hypothalamus and brain stem (two cardioregulatory-relevant brain areas) in two genetic strains of hypertensive rats and (2) analyze the role of adducins in neurotransmission at the cellular level. All three adducin subunits ({alpha}, ß, and {gamma}) were present in the hypothalamus and brain stem of Wister Kyoto (WKY) and spontaneously hypertensive (SH) rats. However, only the {gamma}-adducin subunit expression was 40% to 60% lower in the SH rat compared with WKY rat. A similar decrease in {gamma}-adducin expression was observed in the hypothalamus and brain stem of the renin transgenic rat compared with its normotensive control. Losartan treatment of the SH rat failed to normalize {gamma}-adducin gene expression. A hypertension-linked decrease of {gamma}-adducin was confirmed by demonstrating a decrease in {gamma}-adducin expression in hypothalamic/brain stem neuronal cultures from prehypertensive SH rats. Neuronal firing rate was evaluated to analyze the role of this protein in neurotransmission. Perfusion of a {gamma}-adducin-specific antibody caused a 2-fold increase in the neuronal firing rate, an effect similar to that observed with angiotensin II. Finally, we observed that preincubation of neuronal cultures for 8 hours with 100 nmol/L angiotensin II caused a 60% decrease in endogenous {gamma}-adducin and was associated with a 2-fold increase in basal firing rate. These observations support our hypothesis that a decrease in {gamma}-adducin expression in cardioregulatory relevant brain areas is linked to hypertension possibly by regulating the release of neurotransmitters.


Key words: hypothalamus • brain stem • gene profiling • neurons • {gamma}-adducin




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Bianchi
Genetic variations of tubular sodium reabsorption leading to "primary" hypertension: from gene polymorphism to clinical symptoms
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1536 - R1549.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Bianchi, P. Ferrari, and J. A. Staessen
Adducin Polymorphism: Detection and Impact on Hypertension and Related Disorders
Hypertension, March 1, 2005; 45(3): 331 - 340.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Yang, P. Y. Reaves, M. J. Katovich, and M. K. Raizada
Decrease in Hypothalamic Gamma Adducin in Rat Models of Hypertension
Hypertension, February 1, 2004; 43(2): 324 - 328.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
C. Sun, J. Du, C. Sumners, and M. K. Raizada
PI3-Kinase Inhibitors Abolish the Enhanced Chronotropic Effects of Angiotensin II in Spontaneously Hypertensive Rat Brain Neurons
J Neurophysiol, November 1, 2003; 90(5): 3155 - 3160.
[Abstract] [Full Text] [PDF]